Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Quercetin on Cardiometabolic Outcomes
Sponsor: University of Central Lancashire
Summary
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Quercetin may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
Official title: Effects of Quercetin Supplementation on Cardiometabolic Parameters
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-03-01
Completion Date
2026-12-01
Last Updated
2026-02-27
Healthy Volunteers
Yes
Conditions
Interventions
Quercetin
Quercetin tablets 500mg 1 x per day
Placebo
Placebo control 1 x blinded placebo tablet per day
Locations (1)
University of Central Lancashire
Preston, Lancashire, United Kingdom